Profile data is unavailable for this security.
About the company
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
- Revenue in USD (TTM)1.37bn
- Net income in USD164.31m
- Incorporated1949
- Employees5.52k
- LocationStevanato Group SpAPiombino Dese (Pd) Via Molinella, 17PIOMBINO DESE 35017ItalyITA
- Websitehttps://www.stevanatogroup.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DENTSPLY SIRONA Inc | 3.68bn | -598.00m | 2.86bn | 14.00k | -- | 2.13 | -- | 0.7767 | -3.00 | -3.00 | 18.44 | 6.71 | 0.6582 | 3.05 | 5.92 | 262,857.20 | -10.70 | -5.83 | -14.50 | -7.12 | 50.00 | 52.93 | -16.25 | -11.12 | 1.03 | 4.77 | 0.6347 | -- | -2.98 | 1.96 | 34.29 | -- | 8.53 | 9.86 |
| 10X Genomics Inc | 642.82m | -43.54m | 2.96bn | 1.18k | -- | 3.71 | -- | 4.60 | -0.3496 | -0.3496 | 5.15 | 6.24 | 0.6559 | 2.85 | 9.53 | 545,690.10 | -4.44 | -14.35 | -5.16 | -16.43 | 69.13 | 72.27 | -6.77 | -24.50 | 4.09 | -- | 0.00 | -- | 5.25 | 16.55 | 76.16 | -- | -31.16 | -- |
| Haemonetics Corp | 1.32bn | 175.44m | 2.97bn | 3.02k | 17.55 | 3.28 | 10.31 | 2.25 | 3.64 | 3.64 | 27.40 | 19.46 | 0.525 | 1.58 | 6.47 | 436,081.70 | 6.99 | 5.41 | 8.30 | 6.55 | 59.32 | 53.20 | 13.31 | 9.18 | 1.15 | 12.69 | 0.5733 | 0.00 | 3.95 | 6.60 | 42.64 | 16.99 | 4.37 | -- |
| Integer Holdings Corp | 1.85bn | 102.83m | 2.97bn | 11.00k | 30.06 | 1.70 | 12.72 | 1.60 | 2.87 | 2.87 | 52.83 | 50.85 | 0.5714 | 5.37 | 4.59 | -- | 3.17 | 3.26 | 3.41 | 3.51 | 27.39 | 26.88 | 5.55 | 6.07 | 2.23 | 6.04 | 0.41 | -- | 7.98 | 11.54 | -15.05 | 5.89 | 12.09 | -- |
| ICU Medical Inc | 2.23bn | 732.00k | 3.63bn | 13.00k | 5,955.83 | 1.71 | 17.74 | 1.63 | 0.0247 | 0.0247 | 90.50 | 86.03 | 0.5406 | 2.35 | 12.28 | 171,635.50 | 0.0465 | -0.6518 | 0.0534 | -0.7376 | 36.84 | 34.16 | 0.0861 | -1.11 | 1.15 | 1.70 | 0.378 | -- | -6.33 | 11.91 | 100.62 | -61.53 | -0.6816 | -- |
| LivaNova PLC | 1.39bn | -242.47m | 3.84bn | 3.30k | -- | 3.20 | -- | 2.77 | -4.47 | -4.47 | 25.37 | 21.96 | 0.543 | 2.84 | 6.79 | 420,622.10 | -9.48 | -3.21 | -12.39 | -3.97 | 68.04 | 68.27 | -17.46 | -6.55 | 1.16 | 3.67 | 0.2389 | -- | 10.74 | 8.24 | -483.45 | -- | 18.27 | -- |
| iRhythm Holdings, Inc | 747.14m | -44.55m | 4.15bn | 2.40k | -- | 27.16 | -- | 5.56 | -1.41 | -1.41 | 23.35 | 4.73 | 0.7657 | 12.33 | 9.60 | 311,307.50 | -4.57 | -16.40 | -5.28 | -19.65 | 70.57 | 68.67 | -5.96 | -19.44 | 4.48 | -- | 0.8096 | -- | 26.24 | 23.02 | 60.67 | -- | 27.88 | -- |
| Merit Medical Systems Inc | 1.52bn | 128.49m | 4.55bn | 7.50k | 35.99 | 2.87 | 17.85 | 3.00 | 2.13 | 2.13 | 25.07 | 26.66 | 0.594 | 2.43 | 7.70 | 202,120.80 | 5.03 | 4.56 | 5.53 | 5.10 | 48.70 | 46.73 | 8.48 | 7.34 | 2.95 | 16.77 | 0.3166 | 0.00 | 11.75 | 9.48 | 6.76 | -- | 11.48 | -- |
| Stevanato Group SpA | 1.37bn | 164.31m | 4.57bn | 5.52k | 25.07 | 2.45 | 17.44 | 3.34 | 0.602 | 0.602 | 5.01 | 6.16 | 0.5058 | 2.95 | 2.65 | 247,752.80 | 6.08 | 8.02 | 7.63 | 10.94 | 29.27 | 31.01 | 12.01 | 13.24 | 1.30 | 30.00 | 0.2386 | 6.82 | 1.72 | 15.53 | -19.13 | 24.61 | 33.52 | -- |
| Envista Holdings Corp | 2.72bn | 47.00m | 4.82bn | 12.00k | 107.07 | 1.55 | 29.60 | 1.77 | 0.275 | 0.275 | 16.10 | 18.96 | 0.4931 | 4.62 | 6.86 | 226,625.00 | 0.8523 | -2.14 | 1.01 | -2.58 | 55.02 | 56.70 | 1.73 | -5.21 | 2.04 | 6.70 | 0.318 | -- | 8.32 | 7.11 | 104.20 | 2.03 | -1.03 | -- |
| Lantheus Holdings Inc | 1.54bn | 233.56m | 4.93bn | 1.19k | 22.69 | 4.52 | 16.23 | 3.20 | 3.36 | 3.36 | 22.33 | 16.87 | 0.7328 | 9.04 | 4.53 | 1,292,212.00 | 11.10 | 11.26 | 12.85 | 12.98 | 61.10 | 61.61 | 15.15 | 14.47 | 2.51 | -- | 0.3432 | 0.00 | 0.5019 | 35.35 | -25.25 | -- | 23.67 | -- |
| TransMedics Group Inc | 605.49m | 188.99m | 5.04bn | 898.00 | 30.88 | 10.65 | 23.31 | 8.33 | 4.76 | 4.79 | 14.94 | 13.81 | 0.6467 | 5.09 | 6.65 | 674,269.50 | 20.19 | 4.75 | 21.93 | 5.18 | 59.92 | 61.27 | 31.21 | 8.52 | 6.59 | 84.70 | 0.5199 | 0.00 | 37.13 | 88.21 | 436.58 | -- | 164.81 | -- |
| Teleflex Inc | 2.39bn | 58.53m | 5.43bn | 15.50k | 99.15 | 1.74 | 23.00 | 2.27 | 1.24 | -20.56 | 53.59 | 70.70 | 0.341 | 2.23 | 5.95 | 154,489.00 | 0.8335 | 3.12 | 0.9266 | 3.43 | 53.13 | 57.05 | 2.44 | 10.06 | 2.01 | 2.73 | 0.4581 | 28.48 | 17.25 | -4.72 | 2.34 | -29.49 | 0.9821 | 0.00 |
| Caris Life Sciences Inc | -100.00bn | -100.00bn | 5.84bn | -- | -- | 12.18 | -- | -- | -- | -- | -- | 1.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 9.36 | -- | 0.4404 | -- | 34.67 | -- | 18.22 | -- | -- | -- |
| Avantor Inc | 6.55bn | -530.20m | 6.01bn | 13.50k | -- | 1.08 | -- | 0.9171 | -0.7775 | -0.7775 | 9.62 | 8.16 | 0.5481 | 5.70 | 6.21 | 485,348.20 | -4.44 | 2.78 | -5.17 | 3.18 | 32.65 | 33.77 | -8.09 | 5.00 | 1.18 | 3.62 | 0.4149 | 0.00 | -3.41 | 0.4913 | -174.52 | -- | 15.90 | -- |
| Bruker Corp | 3.44bn | -22.50m | 6.06bn | 11.09k | -- | 2.47 | 30.44 | 1.76 | -0.1485 | -0.1485 | 22.63 | 16.15 | 0.5705 | 1.64 | 5.22 | 310,013.50 | -0.1212 | 5.07 | -0.1553 | 6.76 | 47.13 | 49.70 | -0.2124 | 7.56 | 0.8553 | 9.30 | 0.4268 | 13.19 | 2.08 | 11.57 | -119.89 | -- | 4.34 | 4.56 |
Data as of Mar 03 2026. Currency figures normalised to Stevanato Group SpA's reporting currency: US Dollar USD
63.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Conestoga Capital Advisors LLCas of 31 Dec 2025 | 7.89m | 15.87% |
| Neuberger Berman Investment Advisers LLCas of 31 Dec 2025 | 4.79m | 9.63% |
| T. Rowe Price Investment Management, Inc.as of 31 Dec 2025 | 3.92m | 7.89% |
| TimesSquare Capital Management LLCas of 31 Dec 2025 | 3.50m | 7.04% |
| Thrivent Asset Management LLCas of 31 Dec 2025 | 2.36m | 4.74% |
| Artisan Partners LPas of 31 Dec 2025 | 2.35m | 4.73% |
| BAMCO, Inc.as of 31 Dec 2025 | 2.00m | 4.03% |
| Jennison Associates LLCas of 31 Dec 2025 | 1.77m | 3.57% |
| Silvercross Investment Management BVas of 31 Jul 2025 | 1.47m | 2.96% |
| Ranger Investment Management LPas of 31 Dec 2025 | 1.28m | 2.57% |
More ▼
Data from 31 Jul 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
